Tag: coronavirus vaccine

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More

G42 Healthcare begins phase 3 trial of Sinopharm COVID-19 inactivated vaccine candidate in UAE

pharmanewsdaily- July 20, 2020

Sinopharm COVID-19 inactivated vaccine candidate : Chinese vaccine manufacturer Sinopharm CNBG has launched a phase 3 trial of its COVID-19 inactivated vaccine candidate, in collaboration ... Read More

BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status

pharmanewsdaily- July 14, 2020

Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track ... Read More

Imperial College begins human trial of coronavirus vaccine candidate COVAC1

pharmanewsdaily- June 24, 2020

Imperial College London said that it has dosed the first healthy volunteer with its COVAC1 coronavirus vaccine candidate, which has been developed using the new ... Read More

Catalent wins contract to manufacture AZD1222 COVID-19 vaccine candidate

pharmanewsdaily- June 16, 2020

US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility ... Read More

Intranasal COVID-19 vaccine : Intravacc, WBVR and Utrecht University join forces for vaccine development

pharmanewsdaily- June 5, 2020

Dutch vaccine maker Intravacc has forged a partnership with Wageningen Bioveterinary Research (WBVR) and Utrecht University in the Netherlands to develop an intranasal COVID-19 vaccine. ... Read More

Merck to acquire coronavirus vaccine candidate developer Themis Bioscience

pharmanewsdaily- May 27, 2020

Merck acquisition of Themis Bioscience : Merck has signed a deal to acquire Themis Bioscience, an Austrian vaccine developer for an undisclosed price with an ... Read More

Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

pharmanewsdaily- May 19, 2020

Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer ... Read More

Verndari begins preclinical testing of COVID-19 vaccine candidate

pharmanewsdaily- April 30, 2020

Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. ... Read More

SARS-CoV-2 vaccine trial : Sinovac Biotec begins COVID-19 vaccine candidate human trial

pharmanewsdaily- April 25, 2020

SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2 vaccine, its COVID-19 vaccine candidate in 144 ... Read More